Biomedical Engineering Reference
In-Depth Information
58. Abbas A, Lichtman AH, Pober J. Effector mechanisms of cellular immunity.
In: Cellular and Molecular Immunology. Vol. 13. 4th ed. Philadelphia: WB
Saunders, 2000:291-308 [Chapter 13: 291-308].
59. Richmond I, Prichard GE, Ashcroft T, Avery A, Corris PA, Walters EH.
Bronchial associated lymphoid tissue (BALT) in human lung: its distribution
in smokers and nonsmokers. Thorax 1993; 48:1130-1134.
60. Sethi S, Wrona C, Grant BJ, Murphy TF. Strain-specific immune response to
Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir
Crit Care Med 2004; 169:448-453.
61. Abbe Abe Y, Murphy TF, Sethi S, Faden HS, Dmochowski J, Harabuchi Y,
Thanavala Ym. Lymphocyte proliferative response to P6 of Haemophilus influ-
enzae is associated with relative protection from exacerbations of chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165:967-971.
62. Toelstra A, Vogel L, van Alphen Leijik P, Jansen H, Dankert J. Opsonic anti-
bodies on outer membrane protein P-2 of nonencapsulated H-Flu are strain
specific. Infect Immun 1994; 62:779-784.
63. Wang X, Moser C, Louboutin JP, Lysenko ES, Weiner DJ, Wilson JM. Toll
like receptor 4 mediates innate immune responses to Haemophilus influenzae
infection in mouse lung. J Immunol 2002; 168:810-815.
64. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saacla JI, West AB.
Myofibroblasts I. Paracrine cells important in health and disease. Am J Physiol
Cell Physiol 1999; 277:C1-C19.
65. Kapanci Y, Burgan S, Pietra GG, Conne B, Gabbiani G. Modulation of actin
isoform expression in alveolar myofibroblasts (contractile interstitial cells)
during pulmonary hypertension. Am J Pathol 1990; 136:881-889.
66. Berschneider HM, Powell DW. Fibroblasts modulate intestinal secretory
responses to inflammatory mediators. J Clin Invest 1992; 89:484-489.
67. Hinterleitner TA, Saada JI, Berschneider HM, Powell DW, Valentich JD. IL-1
stimulates intestinal myofibroblast COX gene expression and augments activa-
tion of Cl-secretion in T84 cells. Am J Physiol 1996; 271:C1262-C1268.
68. Tetsuka T, Baier LD, Morrison AR. Antioxidants inhibit interleukin-1-induced
cyclooxygenase and nitric-oxide synthase expression in rat mesangial cells. Evi-
dence for post-transcriptional regulation. J Biol Chem 1996; 271:11689-11693.
69. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters M.
Golden cultured lung fibroblasts isolated from patients with idiopathic pulmon-
ary fibrosis have a diminished capacity to synthesize prostaglandin E
2
and to
express cyclooxygenase-2. J Clin Invest 1995; 95:1861-1868.
70. Tetsuka T, Daphna-Iken D, Srivastava SK, Baier LD, DuMaine J, Morrison
AR. Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglan-
din E
2
negatively modulates induction of nitric oxide synthase by interleukin 1.
Proc Natl Acad Sci USA 1994; 91:12168-12172.
71. Hogaboam CM, Smith RE, Kunkel SL. Dynamic interactions between lung
fibroblasts and leukocytes: implications for fibrotic lung disease. Proc Assoc
Am Physicians 1998; 110:313-320.
72. Pang GL, Couch R, Batey R, Clancy A. Cripps GM-CSF, IL-1a, IL-b, IL-6,
IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production
